Human chorionic gonadotropin contributes to maternal immunotolerance and endometrial apoptosis by regulating fas-fas ligand system

Journal of Immunology

Volumn 171, Issue 5, 2003, Pages 2305-2313

  Kayisli, Umit A ^a,b   Selam, Belgin ^a   Guzeloglu Kayisli, Ozlem ^a,b   Demir, Ramazan ^b   Arici, Aydin ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b AKDENIZ UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; FAS ANTIGEN; FAS LIGAND; MESSENGER RNA;

ADULT; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTROPHOBLAST; DECIDUA; ENDOMETRIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL TOLERANCE; LEUKEMIA CELL LINE; NICK END LABELING; NIDATION; PREGNANCY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA CELL; T LYMPHOCYTE; WESTERN BLOTTING;

EID: 0042931246     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.5.2305     Document Type: Article

References (47)

1. Abrahamsohn, P. A., and T. M. Zorn. 1993. Implantation and decidualization in rodents. J. Exp. Zool. 266:603.
2. Loke, Y. W., and A. King. 1995. Cell biology and immunology. In Human Implantation. Y. W. Loke and A. King, eds. Cambridge University Press, Cambridge, p. 5.
3. Bellgrau, D., D. Gold, H. Selawry, J. Moore, A. Franzusoff, and R. C. Duke. 1995. A role for CD95 ligand in preventing graft rejection. Nature 377:630.
4. Griffith, T. S., T. Brunner, S. M. Fletcher, D. R. Green, and T. A. Ferguson. 1995. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270:1189.
5. Mor, G., L. S. Gutierrez, M. Eliza, F. Kahyaoglu, and A. Arici. 1998. Fas-fas ligand system-induced apoptosis in human placenta and gestational trophoblastic disease. Am. J. Reprod. Immunol. 40:89.
6. Kauma, S. W., T. F. Huff, N. Hayes, and A. Nilkaeo. 1999. Placental Fas ligand expression is a mechanism for maternal immune tolerance to the fetus. J. Clin. Endocrinol Metab. 84:2188.
7. Selam, B., U. A. Kayisli, N. Mulayim, and A. Arici. 2001. Regulation of Fas ligand expression by estradiol and progesterone in human endometrium. Biol. Reprod. 65:979.
8. Galan, A., R. Herrer, J. Remohi, A. Pellicer, and C. Simon. 2000. Embryonic regulation of endometrial epithelial apoptosis during human implantation. Hum. Reprod. 15(Suppl. 6):74.
9. Von Rango, U., I. Classen-Linke, C. A. Krusche, and H. M. Beier. 1998. The receptive endometrium is characterized by apoptosis in the glands. Hum. Reprod. 13:3177.
10. Bernardini, L., I. Moretti-Rojas, M. Brush, F. J. Rojas, and J. P. Balmaceda. 1995. Status of hCG/LH receptor and G proteins in human endometrium during artificial cycles of hormone replacement therapy. J. Soc. Gynecol. Investig. 2:630.
11. Tang, B., and E. Gurpide. 1993. Direct effect of gonadotropins on decidualization of human endometrial stroma cells. J. Steroid Biochem. Mol. Biol. 47:115.
12. Chen, J. C., J. H. Lin, G. M. Jow. Y. I. Peng, T. H. Su, Y. F. Tsai, and T. J. Chen. 2001. Involvement of apoptosis during deciduomal regression in pseudopregnant hamsters effect of progesterone. Life Sci. 68:815.
13. Hirabayashi, H., T. Sato, S. Kohno, M. Tanaka, S. Kobayashi, Y. Ohta, and T. Iguchi. 1999. Apoptotic cell death in artificially induced deciduoma of pseudopregnant mice. Anat. Rec. 254:205.
14. Arici, A., J. R. Head, P. C. MacDonald, and M. L. Casey. 1993. Regulation of interleukin-8 gene expression in human endometrial cells in culture. Mol. Cell. Endocrinol. 94:195.
15. Selam, B., U. A. Kayisli, J. A. Garcia-Velasco, G. E. Akbas, and A. Arici. 2002. Regulation of fas ligand expression by IL-8 in human endometrium. J. Clin. Endocrinol. Metab. 87:3921.
16. Gilbert, S. F., and B. R. Migeon. 1975. D-valine as a selective agent for normal human and rodent epithelial cells in culture. Cell 5:11.
17. Nagata, S., and P. Golstein. 1995. The Fas death factor. Science 267:1449.
18. Carmichael, J., W. G. DeGraff, A. F. Gazdar, J. D. Minna, and J. B. Mitchell. 1987. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of radiosensitivity. Cancer Res. 47:943.
19. Suda, T., T. Takahashi, P. Golstein, and S. Nagata. 1993. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169.
20. Uckan, D., A. Steele, Cherry, B. Y. Wang, W. Chamizo, A. Koutsonikolis, E. Gilbert-Barness, and R. A. Good. 1997. Trophoblasts express Fas ligand: a proposed mechanism for immune privilege in placenta and maternal invasion. Mol. Hum. Reprod. 3:655.
21. Runic, R., C. J. Lockwood, Y. Ma, B. Dipasquale, and S. Guller. 1996. Expression of Fas ligand by human cytotrophoblasts: implications in placentation and fetal survival. J. Clin. Endocrinol. Metab. 81:3119.
22. Hussa, R. O. 1980. Biosynthesis of human chorionic gonadotropin. Endocr. Rev. 1:268.
23. Rao, C. V. 1982. Receptors for gonadotropins in human ovaries. In Recent Advances in Fertility Research. T. G. Muldoon, V. B. Mahesh, and B. Perez-Ballester, eds. New York Press, New York, p. 123.
24. Catt, K. J., J. P. Harwood, R. N. Clayton, T. F. Davies, V. Chan, M. Katikineni, K. Nozu, and M. L. Dufau. 1980. Regulation of peptide hormone receptors and gonadal steroidogenesis. Recent Prog. Horm. Res. 36:557.
25. Reshef, E., Z. M. Lei, C. V. Rao, D. D. Pridham, N. Chegini, and J. L. Luborsky. 1990. The presence of gonadotropin receptors in nonpregnant human uterus, human placenta, fetal membranes, and decidua. J. Clin. Endocrinol. Metab. 70:421.
26. Lehmann, W. D., and C. Lauritzen. 1975. HCG + ACTH stimulation of in vitro dehydroepiandrosterone production in human fetal adrenals from precursor cholesterol and δ5-pregnenolone. J. Perinat. Med. 3:231.
27. Han, S. W., Z. M. Lei, and C. V. Rao. 1999. Treatment of human endometrial stromal cells with chorionic gonadotropin promotes their morphological and functional differentiation into decidua. Mol. Cell. Endocrinol. 147:7.
28. + double-positive thymocytes. J. Immunol. 164:1689.
29. Welsh, A. O. 1993. Uterine cell death during implantation and early placentation. Microsc. Res. Tech. 25:223.
30. 3 in T lymphocytes. J. Immunol. 168:1154.
31. Lei, Z. M., C. V. Rao, D. M. Ackerman, and T. G. Day. 1992. The expression of human chorionic gonadotropin/human luteinizing hormone receptors in human gestational trophoblastic neoplasms. J. Clin. Endocrinol. Metab. 74:1236.
32. Lin, J., Z. M. Lei, S. Lojun, C. V. Rao, P. G. Satyaswaroop, and T. G. Day. 1994. Increased expression of luteinizing hormone/human chorionic gonadotropin receptor gene in human endometrial carcinomas. J. Clin. Endocrinol. Metab. 79:1483.
33. Lei, Z. M., C. V. Rao, S. R. Lincoln, and D. M. Ackermann. 1993. Increased expression of human chorionic gonadotropin/human luteinizing hormone receptors in adenomyosis. J. Clin. Endocrinol. Metab. 76:763.
34. Lincoln, S. R., Z. M. Lei, C. V. Rao, and M. A. Yussman. 1992. The expression of human chorionic gonadotropin/human luteinizing hormone receptors in ectopic human endometrial implants. J. Clin. Endocrinol. Metab. 75:1140.
35. Makrigiannakis, A., E. Zoumakis, S. Kalantaridou, C. Coutifaris, A. N. Margioris, G. Coukos, K. C. Rice, A. Gravanis, and G. P. Chrousos. 2001. Corticotropin-releasing hormone promotes blastocyst implantation and early maternal tolerance. Nat. Immun. 2:1018.
36. Nagata, S. 1994. Apoptosis regulated by a death factor and its receptor: Fas ligand and Fas. Philos. Trans. R. Soc. Lond. B Biol. Sci. 345:281.
37. Nagata, S., and T. Suda. 1995. Fas and Fas ligand: lpr and gld mutations. Immunol. Today 16:39.
38. Aoki, K., M. Kurooka, J. J. Chen, J. Petryniak, E. G. Nabel, and G. J. Nabel. 2001. Extracellular matrix interacts with soluble CD95L: retention and enhancement of cytotoxicity. Nat. Immun. 2:2333.
39. Gregory, M. S., A. C. Repp, A. M. Holhbaum, R. R. Saff, A. Marshak-Rothstein, and B. R. Ksander. 2002. Membrane Fas ligand activates innate immunity and terminates ocular immune privilege. J. Immunol. 169:2727.
40. Knox, P. G., A. E. Milner, N. K. Green, A. G. Eliopoulos, and L. S. Young. 2003. Inhibition of metalloproteinase cleavage enhances the cytotoxicity of Fas ligand. J. Immunol. 170:677.
41. Loke, Y. W., and A. King. 2000. Immunology of implantation. Baillieres Best Pract. Res. Clin. Obstet. Gynaecol., 14:827.
42. Reinhard, G., A. Noll, H. Schlebusch, P. Mallmannn, and A. V. Ruecker. 1998. Shifts in the TH1/TH2 balance during human pregnancy correlate with apoptotic changes. Biochem. Biophys. Res. Commun. 245:933.
43. Samaniego, F., J. L. Bryant, N. Liu, J. E. Karp, A. L. Sabichi, A. Thierry, Y. Lunardi-Iskandar, and R. C. Gallo. 1999. Induction of programmed cell death in Kaposi's sarcoma cells by preparations of human chorionic gonadotropin. J. Natl. Cancer Inst. 91:135.
44. Srivastava, P., J. Russo, O. P. Mgbonyebi, and I. H. Russo. 1998. Growth inhibition and activation of apoptotic gene expression by human chorionic gonadotropin in human breast epithelial cells. Anticancer Res. 18:4003.
45. Fazleabas, A. T., and Z. Strakova. 2002. Endometrial function: cell specific changes in the uterine environment. Mol. Cell Endocrinol. 186:143.
46. Srisuparp, S., Z. Strakova, and A. T. Fazleabas. 2001. The role of chorionic gonadotropin (CG) in blastocyst implantation. Arch. Med. Res. 32:627.
47. Fazleabas, A. T., K. M. Donnelly, S. Srinivasan, J. D. Fortman, and J. B. Miller. 1999. Modulation of the baboon (Papio anubis) uterine endonietrium by chorionic gonadotrophin during the period of uterine receptivity. Proc. Natl. Acad. Sci. USA 96:2543.